Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 1
2008 1
2009 2
2010 1
2011 3
2012 1
2013 1
2014 1
2015 2
2016 1
2017 3
2019 3
2021 1
2022 1
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).
Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A, Hines M, Eckstein O, Ladisch S, Nichols KE, Rodriguez-Galindo C, Wistinghausen B, McClain KL. Jordan MB, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2019 Nov;66(11):e27929. doi: 10.1002/pbc.27929. Epub 2019 Jul 24. Pediatr Blood Cancer. 2019. PMID: 31339233 Free PMC article. Review.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
How I approach B-lymphoblastic lymphoma in children.
Devine KJ, Fries C, Hermiston M, Wistinghausen B. Devine KJ, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2023 Aug;70(8):e30401. doi: 10.1002/pbc.30401. Epub 2023 May 9. Pediatr Blood Cancer. 2023. PMID: 37158503
Management of post-transplant lymphoproliferative disorders.
Llaurador G, McLaughlin L, Wistinghausen B. Llaurador G, et al. Among authors: wistinghausen b. Curr Opin Pediatr. 2017 Feb;29(1):34-40. doi: 10.1097/MOP.0000000000000445. Curr Opin Pediatr. 2017. PMID: 27906865 Review.
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
El-Mallawany NK, Alexander S, Fluchel M, Hayashi RJ, Lowe EJ, Giulino-Roth L, Wistinghausen B, Hermiston M, Allen CE; COG NHL Committee. El-Mallawany NK, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30565. doi: 10.1002/pbc.30565. Epub 2023 Jul 14. Pediatr Blood Cancer. 2023. PMID: 37449925
Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues.
Meyer JA, Zhou D, Mason CC, Downie JM, Rodic V, Abromowitch M, Wistinghausen B, Termuhlen AM, Angiolillo AL, Perkins SL, Lones MA, Barnette P, Schiffman JD, Miles RR. Meyer JA, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26363. Epub 2016 Dec 13. Pediatr Blood Cancer. 2017. PMID: 27957801
Children's Oncology Group's 2023 blueprint for research: Young investigators.
Esbenshade AJ, Kahalley LS, Wistinghausen B, Cash T, Baertschiger RM, Zarnegar-Lumley S, Green A, Dhall G; COG Young Investigators Committee. Esbenshade AJ, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30567. doi: 10.1002/pbc.30567. Epub 2023 Jul 12. Pediatr Blood Cancer. 2023. PMID: 37438856
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.
Wistinghausen B, Toner K, Barkauskas DA, Jerkins LP, Kinoshita H, Chansky P, Pezzella G, Saguilig L, Hayashi RJ, Abhyankar H, Scull B, Karri V, Tanna J, Hanley P, Hermiston ML, Allen CE, Bollard CM. Wistinghausen B, et al. Blood Adv. 2024 Mar 12;8(5):1116-1127. doi: 10.1182/bloodadvances.2023010832. Blood Adv. 2024. PMID: 38163318 Free PMC article.
29 results